
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18211593
[patent_doc_number] => 20230057856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => CELL CULTURE METHODS AND MEDIA COMPRISING N-ACETYLCYSTEINE
[patent_app_type] => utility
[patent_app_number] => 17/808410
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808410 | CELL CULTURE METHODS AND MEDIA COMPRISING N-ACETYLCYSTEINE | Jun 22, 2022 | Pending |
Array
(
[id] => 19691362
[patent_doc_number] => 20250009907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => NEAR-INFRARED FLUORESCENT PROBE SPECIFICALLY TARGETING TUMORS AS WELL AS SYNTHESIS METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/907973
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907973 | Near-infrared fluorescent probe specifically targeting tumors as well as synthesis method and use thereof | May 8, 2022 | Issued |
Array
(
[id] => 17807326
[patent_doc_number] => 20220259161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => PSMA-TARGETING COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/718812
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17718812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/718812 | PSMA-targeting compounds and uses thereof | Apr 11, 2022 | Issued |
Array
(
[id] => 18244845
[patent_doc_number] => 20230077156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => NON-DEGRADABLE, LOW SWELLING, WATER SOLUBLE RADIOPAQUE HYDROGEL POLYMER
[patent_app_type] => utility
[patent_app_number] => 17/717768
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717768 | NON-DEGRADABLE, LOW SWELLING, WATER SOLUBLE RADIOPAQUE HYDROGEL POLYMER | Apr 10, 2022 | Pending |
Array
(
[id] => 20386521
[patent_doc_number] => 12486238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Compound having antibacterial function against superbacteria and selective detection function of hypochlorous acid, and composition and sensor comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/705007
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3090
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705007
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705007 | Compound having antibacterial function against superbacteria and selective detection function of hypochlorous acid, and composition and sensor comprising the same | Mar 24, 2022 | Issued |
Array
(
[id] => 17719163
[patent_doc_number] => 20220211882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => METHOD AND DEVICE FOR PRODUCING OPTIMIZED LIPID-BASED MICRO/NANO-BUBBLES
[patent_app_type] => utility
[patent_app_number] => 17/700356
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700356 | METHOD AND DEVICE FOR PRODUCING OPTIMIZED LIPID-BASED MICRO/NANO-BUBBLES | Mar 20, 2022 | Pending |
Array
(
[id] => 18127988
[patent_doc_number] => 11554184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseases
[patent_app_type] => utility
[patent_app_number] => 17/697416
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16704
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697416 | Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseases | Mar 16, 2022 | Issued |
Array
(
[id] => 17895484
[patent_doc_number] => 20220305146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR INFECTIOUS DISEASE DIAGNOSIS AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/697401
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697401
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697401 | RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR INFECTIOUS DISEASE DIAGNOSIS AND THERAPY | Mar 16, 2022 | Abandoned |
Array
(
[id] => 17898381
[patent_doc_number] => 20220308043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO
[patent_app_type] => utility
[patent_app_number] => 17/696315
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696315 | FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO | Mar 15, 2022 | Pending |
Array
(
[id] => 17687638
[patent_doc_number] => 20220194930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 17/693011
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693011 | Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same | Mar 10, 2022 | Pending |
Array
(
[id] => 17827969
[patent_doc_number] => 20220265273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COLLAGEN MATRIX AND N-HYDROXYLSUCCINIMIDE FUNCTIONALIZED POLYETHYLENE GLYCOL STAPLE LINE REINFORCEMENT
[patent_app_type] => utility
[patent_app_number] => 17/677570
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677570
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677570 | COLLAGEN MATRIX AND N-HYDROXYLSUCCINIMIDE FUNCTIONALIZED POLYETHYLENE GLYCOL STAPLE LINE REINFORCEMENT | Feb 21, 2022 | Pending |
Array
(
[id] => 17520426
[patent_doc_number] => 20220106275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => RADIOLABELED COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/553462
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553462 | RADIOLABELED COMPOUNDS AND USES THEREOF | Dec 15, 2021 | Pending |
Array
(
[id] => 17503425
[patent_doc_number] => 20220096527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/542358
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542358
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542358 | PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION | Dec 2, 2021 | Pending |
Array
(
[id] => 17627226
[patent_doc_number] => 20220162241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Chelated PSMA Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/528571
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528571 | Chelated PSMA Inhibitors | Nov 16, 2021 | Abandoned |
Array
(
[id] => 17441940
[patent_doc_number] => 20220062445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/522249
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522249 | SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS | Nov 8, 2021 | Pending |
Array
(
[id] => 17412820
[patent_doc_number] => 20220047724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => NOVEL TRICARBOCYANINE-CYCLODEXTRIN(S) CONJUGATES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/515080
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17515080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/515080 | NOVEL TRICARBOCYANINE-CYCLODEXTRIN(S) CONJUGATES AND USE THEREOF | Oct 28, 2021 | Pending |
Array
(
[id] => 17414031
[patent_doc_number] => 20220048935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Radioactive Phospholipid Metal Chelates for Cancer Imaging and Therapy
[patent_app_type] => utility
[patent_app_number] => 17/511642
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511642 | Radioactive Phospholipid Metal Chelates for Cancer Imaging and Therapy | Oct 26, 2021 | Pending |
Array
(
[id] => 17561806
[patent_doc_number] => 20220125955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PER-ORAL NEGATIVE CONTRAST AGENT FOR ABDOMINAL IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/502372
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502372
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502372 | PER-ORAL NEGATIVE CONTRAST AGENT FOR ABDOMINAL IMAGING | Oct 14, 2021 | Abandoned |
Array
(
[id] => 17342238
[patent_doc_number] => 20220008569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/490389
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490389 | PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS | Sep 29, 2021 | Pending |
Array
(
[id] => 17334459
[patent_doc_number] => 20220000790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/479395
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479395 | FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME | Sep 19, 2021 | Pending |